EYPT:NASDAQ
EyePoint Inc
$4.23
arrow_downward
-0.47%(-0.020) 1D
$4.23
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 11, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
$4.32
High
$4.43
Low
$4.17
Mkt. cap
364.68M
Avg. vol.
5.47M
Volume
2.73M
52-wk high
$19.01
52-wk low
$3.95
EPS
-$3.74
Beta
1.63
Shares outstanding
86.21M
No. of employees
214
Open
$4.32
High
$4.43
Low
$4.17
Mkt. cap
364.68M
Avg. vol.
5.47M
Volume
2.73M
52-wk high
$19.01
52-wk low
$3.95
EPS
-$3.74
Beta
1.63
Shares outstanding
86.21M
No. of employees
214
News stories
From web sources and news partners
GlobeNewswire
·
1 day ago
EYPT Investigation Alert: EyePoint, Inc. Investors Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
TradingView
·
1 day ago
EYPT: LUGANO trial showed strong secondary results and safety; LUCIA aims to confirm efficacy for approval
TipRanks
·
1 day ago
EyePoint updates DURAVYU Phase 3 wet AMD data
Stock Titan
·
1 day ago
Eye drug cuts injections 42% in EyePoint (EYPT) trial but misses its main goal
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeyepoint.bio